Venus Concept Inc.
VERO | NASDAQ
$0.40
-$0.12 (-23.09%)
Feb 12, 2026, 3:55 PM ET · Market open
Company Profile
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.
Key Executives
| Name | Position |
|---|---|
| Rajiv Kanishka Liyanaarchchie De Silva | Chief Executive Officer & Director |
| Michael Mandarello | Chief Legal Officer, Head of Strategy & Operations |
| Anna Georgiadis | Chief Human Resources Officer |
| Cliff Oostman | Head of R&D, Robotics, Hardware |
| Domenic Della Penna | Executive VP & CFO |
| Jesus Alvarez-Quintero | Head of Sales - LATAM |
| Joyce Morris | Head of Sales - Canada |
| Melissa Kang | Chief Product Officer |
| Ognjen Petrovic | Head of R&D, Robotics, Software |
| Ross J. Portaro | Executive Vice President of Commercial Strategy & Head of Venus Hair |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 30, 2026 | 25 | Filing |
| Jan 21, 2026 | 8-K | Current Report |
| Jan 15, 2026 | SC 13D/A | [Amend] Filing |
| Jan 07, 2026 | 8-K | Current Report |
| Dec 15, 2025 | SC 13D/A | [Amend] Filing |
| Dec 02, 2025 | 8-K | Current Report |
| Nov 13, 2025 | 10-Q | Quarterly Report |
| Nov 13, 2025 | 8-K | Current Report |
| Oct 31, 2025 | 8-K | Current Report |
| Oct 02, 2025 | SC 13D/A | [Amend] Filing |
Venus Concept Inc.
| Country | Canada |
| IPO Date | Oct 11, 2017 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 292 |
| CEO | Rajiv Kanishka Liyanaarchchie De Silva |
Contact Details
235 Yorkland Boulevard Toronto,
ON M2J 4Y8 Canada
Stock Details
| Ticker Symbol | VERO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001409269 |
| CUSIP Number | 92332W303 |
| ISIN Number | US92332W3034 |
| SIC Code | 3841 |
Add to Watchlist
Select watchlists to add or remove VERO